Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission
Summary
Most of the 51 species embedded in the genus Sporothrix are nonpathogenic environmental fungi that are closely related to decaying wood, plants, and soil. However, members of the Sporothrix schenckii complex are highly successful mammal pathogens, including S. brasiliensis, S. schenckii sensu stricto (s. str.), S. globosa, and S. luriei, the causative agents of human and animal sporotrichosis [https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006077#ppat.1006077.ref001]. Their key to success during mammal infection lies at least in part with their ability to change from a mycelial saprophytic lifestyle at 25°C in the environment to a parasitic yeast cell at an elevated temperature (35°C–37°C), such as those developed by warm-blooded hosts [https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006077#ppat.1006077.ref002]. Typically, infection develops after traumatic inoculation of contaminated soil, plants, and organic matter into skin or mucosa. Alternatively, infection may occur during the animal transmission (cat–cat or cat–dog) and zoonotic transmission (cat–human), which has been mostly associated with scratches or bites from infected cats [https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006077#ppat.1006077.ref002]. In Brazil, S. brasiliensis is repeatedly associated with feline infection and has consistently shown higher virulence during epizootics, as well as in murine models of sporotrichosis. A hallmark of S. brasiliensis infection is its tendency to escalate to outbreaks or epidemics among cats with high potential for zoonotic transmission. Sporotrichosis is an emergent disease and, over the past two decades, the incidence of zoonotic sporotrichosis has been on the rise, particularly in Brazil. Judging from the epizootic and zoonotic epidemics taking place in Rio de Janeiro, Brazil, tackling sporotrichosis requires the engagement of animal and human health policies to reduce the transmission chain of Sporothrix.
Key Points
- 1Sporotrichosis is an emergent disease with rising incidence, particularly in Brazil
- 2Cats play a crucial role in the zoonotic transmission of Sporothrix to humans
- 3Treatment typically involves long-term administration of antifungal medications
- 4Drug resistance to common treatments is a growing concern for sporotrichosis management
- 5Vaccine research is ongoing to prevent infections in felines and reduce transmission risk.
Related articles
Evaluating large language models for clinical note processing: local fine-tuning and internal-external validation using electronic health records from South Asia
This research paper evaluates the effectiveness of large language models for processing clinical notes from electronic health records in South Asia, focusing on local fine-tuning and validation. It discusses the potential application of LLMs in clinical settings, particularly in resource-limited environments.
Cardiac Cycle & Physiology: Understanding Cardiac Function
This document provides a detailed overview of cardiac physiology, including the cardiac cycle, blood flow processes, and the cardiac conduction system. It aims to inform readers about the mechanics of the heart and its role in circulation.
Cardiac Cycle & Physiology
This document provides a comprehensive overview of cardiac cycle phases, blood flow through the heart, and the electrophysiology of cardiac conduction. It details the processes of deoxygenation and oxygenation of blood and the physiological aspects of cardiac output and common cardiovascular assessment findings.
The Dual Pillars of Clinical and Community Care
This document provides an in-depth examination of nutritional assessment and surveillance in clinical and community settings, offering guidelines on measuring malnutrition indicators and the importance of dietary interventions.
Cather Simpson Lecture Research Brief Inaugural David Breen
Cather Simpson Lecture Research Brief Inaugural David Breen Lecture | 14 October 2026 | 12 pm to 1 pm | AM103 The "Nespresso" of Diagnostics: Centrifugal Microfluidics for Point-of-Care Diagnostics; “Can we